Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report)’s share price rose 5.5% on Monday . The stock traded as high as $20.77 and last traded at $20.74. Approximately 65,585 shares changed hands during trading, a decline of 94% from the average daily volume of 1,191,632 shares. The stock had previously closed at $19.66. Analysts Set […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) COO Jonathan Young sold 5,000 shares of the firm’s stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $20.15, for a total transaction of $100,750.00. Following the completion of the sale, the chief operating officer now owns 258,306 shares […]
Clough Capital Partners L P bought a new stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor bought 72,200 shares of the company’s stock, valued at approximately $3,652,000. A number of other hedge funds and other institutional investors also recently bought and sold […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) insider Catriona Yale sold 597 shares of the firm’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $20.76, for a total value of $12,393.72. Following the sale, the insider now owns 77,910 shares of the company’s stock, valued […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) CEO Andrew Cheng sold 7,405 shares of the stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $20.02, for a total value of $148,248.10. Following the transaction, the chief executive officer now owns 552,539 shares of the […]